$DMTK has a bright future. This is going to be a hypergrowth company for the next 3-4 years with current PLA product + Luminate + other genomics skin testing products in the pipeline.
Here is my recent interview with Thomas Sandgaard, Founder & CEO of @ZynexMedical aka $ZYXI
$ZYXI devices are used for pain management and recovery from injury/surgery -- hopefully instead of opioids
Watch here:
$ZYXI is the leader in electro-stimulation devices and they are 10x better than the crappy ones you buy on Amazon
$ZYXI devices have to be prescribed by a medical professional and given that my entire body hurts most days I'll be visiting my doctor very soon to get one.
$ZYXI is $80+ million in revenues in 2020 which was 76% YoY growth
$ZYXI also has 78% gross margins and is already profitable.
Thomas thinks $ZYXI can do $150M in 2021 and $300M in 2022
$ZYXI doubled the size of their sales force in 2020 and now have 500+ sales people.
Several people have asked me why I'm willing to pay 65x sales for $DMTK - it's a good question so here's my answer:
When you find a company like $DMTK that has the potential to grow revenues at 200% annually for the next 4+ years you don't sit back and wait for it to look cheap.
By the time $DMTK looks cheap it might be a $30+ billion company.
You have to adjust your mindset in you want to invest in these hypergrowth companies that have a smaller revenue base now but massive upside thanks to years of insane growth in the future.
Here are my revenue projections for $DMTK based on their current PLA product, Luminate, PLA+ and several other pipeline products:
Seems like two bad weeks in the markets brings out the worst in some people. It’s too bad b/c I love twitter but some people make it intolerable on certain days. It’s sad that these people have nothing better to do than create fake profiles for the purpose of harassing others.
I have always done my best to provide/create valuable content and help others become better investors.
I’m far from perfect. I don’t have a crystal ball. I make plenty of mistakes like everyone else.
All I can do is try my hardest to find great companies that can deliver strong returns for investors.
I have no idea what these companies will do in the short term. These are companies I want to own for many years.
Just wrapped up a great interview with Thomas Sandgaard, Founder & CEO of $ZYXI -- @ZynexMedical
It's insane how undervalued $ZYXI is right now. The company has already given guidance for 2021 revenues around $150M and Thomas thinks they might be able to do $300M in 2022.
With a market cap under $500M this stock is trading at 3x 2021 sales and less than 2x 2022 sales.
Did I mention they have 78% gross margins and are already profitable.
They also have two new products coming to market later this year: 1) blood flow/loss monitor 2) sepsis monitor
It's worth mentioning that Thomas owns 46% of the company so he has more skin in the game than the average Founder or CEO -- I love this.
This interview will be sent to all Substack paid subscribers later today and then my free subscribers will get it later this week.
@OwletBabyCare is currently on the 3rd generation of their "smart sock" with a bunch of products in the pipeline including the pregnancy band and smart scale.
@OwletBabyCare wants to build the leading babytech company which includes the connected nursery and digital parenting platform.
@owletbabycare has a strong management team and the SPAC sponsor (Sandbridge) is the perfect group to take them public and help them scale.